CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Prolung Inc  (FRES)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
 
 

FRES's Net Income Year on Year Growth by Quarter and Year

Prolung Inc's Net Income results by quarter and year



Select the Comparisons : Select the Ratio:                        
FRES Net Income (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - -0.69 -0.87 -0.38
III Quarter September - -0.67 -0.87 -0.46
II Quarter June - -0.61 -0.64 -0.64
I Quarter March -0.96 -0.81 -0.42 -0.45
FY   -0.96 -2.78 -2.80 -1.93

Financial Statements
Prolung Inc's first quarter 2017 Net Income $ -0.96 millions FRES's Income Statement
Prolung Inc's first quarter 2016 Net Income $ -0.81 millions Quarterly FRES's Income Statement
FRES's Growth by Division See FRES's Growth by Segment

FRES Net Income ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -



FRES Net Income Growth Comment
Prolung Inc in the first quarter recorded net loss of $ -0.96 millions.

According to the results reported in the first quarter, Prolung Inc achieved the best Net Income growth in Medical Laboratories industry. While Prolung Inc' s Net Income no change of % ranks overall at the positon no. 0 in the first quarter.



Net Income Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #0
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

You need to upgrade your Flash Player

Other Net Income Growth
Medical Laboratories Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
FRES's Net Income Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for FRES's Competitors
Net Income Growth for Prolung Inc's Suppliers
Net Income Growth for FRES's Customers

You may also want to know
FRES's Annual Growth Rates FRES's Profitability Ratios FRES's Asset Turnover Ratio FRES's Dividend Growth
FRES's Roe FRES's Valuation Ratios FRES's Financial Strength Ratios FRES's Dividend Payout Ratio
FRES's Roa FRES's Inventory Turnover Ratio FRES's Growth Rates FRES's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Mar 31 2017 within Healthcare SectorY/Y Change %Net Income for the quarter ending Mar 31 2017
Abbott Laboratories  32.59 %$ 32.595 millions
Intuitive Surgical Inc  31.82 %$ 31.818 millions
Alliance Healthcare Services, Inc  31.13 %$ 31.129 millions
Magellan Health Inc  30.45 %$ 30.453 millions
Immucell Corp  29.13 %$ 29.129 millions
Ophthalix, Inc.  29.11 %$ 29.114 millions
Phibro Animal Health Corp  27.27 %$ 27.270 millions
Bristol Myers Squibb Co  26.53 %$ 26.534 millions
Abbvie Inc.  26.37 %$ 26.366 millions
National Research Corporation  26.06 %$ 26.058 millions
U.s. Neurosurgical Holdings, Inc.  22.73 %$ 22.727 millions
Inc Research Holdings, Inc.  21.73 %$ 21.729 millions
Msa Safety Incorporated  21.68 %$ 21.676 millions
Lhc Group, Inc  20.56 %$ 20.561 millions
Chemed Corp  20.14 %$ 20.145 millions
Laboratory Corp Of America Holdings  19.94 %$ 19.938 millions
Biospecifics Technologies Corp  18.23 %$ 18.226 millions
Healthcare Services Group Inc  18.21 %$ 18.206 millions
Celgene Corp  17.52 %$ 17.522 millions
Jazz Pharmaceuticals Plc  16.72 %$ 16.716 millions
Jrsis Health Care Corp  16.70 %$ 16.704 millions
Icon Plc  13.41 %$ 13.412 millions
Stryker Corp  10.45 %$ 10.448 millions
Healthsouth Corp  10.04 %$ 10.039 millions
Utah Medical Products Inc  9.92 %$ 9.916 millions
Vca Inc  9.91 %$ 9.914 millions